Coplavix (clopidogrel, acetylsalicylic acid) coated tablets 75 mg. №28

$125.18

Manufacturer: France

Purpose: Inhibits platelet aggregation, prevents blood clots in cardiovascular diseases.

SKU: MED57437 Category:

Description

Coplavix (Clopidogrel, Acetylsalicylic Acid) Coated Tablets 75 mg. №28

Ingredients

Active substances: Clopidogrel, Acetylsalicylic Acid

Mechanism of Action

Pharmacological Properties: Clopidogrel inhibits platelet aggregation, preventing blood clots that can cause cardiovascular events. Acetylsalicylic acid acts as an anti-inflammatory agent, further reducing the risk of heart attacks and strokes.

Indications for Use

Detailed Indications: Coplavix tablets are indicated for the prevention of blood clots in patients with a history of heart attack, stroke, or peripheral artery disease.

Contraindications

Contraindications: Do not use Coplavix tablets if you are allergic to clopidogrel or acetylsalicylic acid, or if you have a history of bleeding disorders.

Side Effects

Common Side Effects: Possible side effects may include gastrointestinal discomfort, easy bruising, or prolonged bleeding. Contact your healthcare provider if you experience any unusual symptoms.

Usage Instructions

Dosage and Administration: Take one tablet daily with a glass of water, with or without food, as directed by your healthcare provider.

Benefits Compared to Analogues

Advantages Over Analogues: Clinical studies have demonstrated that the combination of clopidogrel and acetylsalicylic acid in Coplavix tablets offers superior efficacy in preventing recurrent heart attacks and strokes compared to using either medication alone.

Suitable Patient Groups

Patient Groups: Coplavix tablets are suitable for adult patients with a history of cardiovascular events. Use in children, pregnant women, or elderly individuals should be based on healthcare provider recommendations.

Storage and Shelf Life

Storage Conditions: Store Coplavix tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use expired tablets.

Packaging Description

Packaging: Each package of Coplavix tablets contains 28 coated tablets of 75 mg strength.

Scientific Evidence

Clinical Studies: Coplavix tablets have been extensively studied in clinical trials for their efficacy in preventing cardiovascular events. Research published in reputable medical journals has shown that the combination of clopidogrel and acetylsalicylic acid significantly reduces the risk of recurrent heart attacks and strokes compared to monotherapy.

Additional Information

Important Instructions: Follow your healthcare provider’s guidance on the use of Coplavix tablets. Inform your doctor about all medications you are taking to prevent drug interactions. Seek immediate medical attention in case of unusual bleeding or bruising.